Clinical trial

Clinical Study of IBI362 in Healthy Chinese Male Subjects

NCT04773977

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention IBI362 liquid formulation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention IBI362 lyophilized powder Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Study of IBI362 in Healthy Chinese Male Subjects

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-03

PhasePHASE1

Conditions

Overweight/Obesityunresolved

Interventions

IBI362 liquid formulationDRUG

IBI362 lyophilized powderDRUG

Sponsors & collaborators

Innovent Biologics (Suzhou) Co. Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04773977 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.